Any current/future new fundraising through debt or equity?

DOMS Industries is currently infusing approximately INR 29 crores as primary infusion in Uniclan as part of their acquisition, with the balance being secondary purchase from existing promoters (Page 12). This primary infusion will support Uniclan's capital requirements for mid-term, including capital expenses for expanding diaper manufacturing capacity and starting the wet wipe segment (Page 12). The current net debt level of Uniclan is about INR 38 crores. Post-capital infusion, some of the infusion will be used for capex and working capital (Page 12). The company did not mention any specific

Any current/future capex/capital investment/strategic investment?

DOMS is expanding manufacturing capacities, including a new 44-acre land parcel under construction since Q1 2024 for core stationery products. Recently commercialized an additional pen manufacturing capacity of 1 million pens per day, increasing total capacity to 3 million pens/day soon. Plans to add pencil manufacturing capacity by end of FY25 or early FY26, increasing from 5.7 million to about 8-8.5 million pieces per day. Acquisition of Uniclan (diaper business) includes a capital infusion of approx. INR 29 crores planned for capacity expansion (adding a third diaper manufacturing line with

Future growth expectations in sales/revenue/volumes?

The company targets about 20% core business revenue growth in FY25, with additional growth from inorganic acquisitions (e.g., Uniclan). Office supplies like pens have a growing production capacity, with pen manufacturing capacity recently expanded to 3 million pens/day and plans to increase pencil capacity by about 2.5 million/day soon. The new pen production unit (1 million pens/day capacity) started operations towards end of June 2024 and utilization will steadily increase. The diaper business (Uniclan acquisition) is expanding capacity from 400 million to 650 million pieces/year, expected t

Future growth expectations in earnings/operating earnings/profits/EPS?

DOMS targets a revenue growth of around 20% in FY25 for its core business, with additional growth expected from inorganic acquisitions like Uniclan. EBITDA margins are expected to normalize to about 17% for the full year, considering increased raw material costs, integration of Uniclan (which has a lower margin), and ESOP expenses. PAT was projected around INR 210 crores by an analyst, aligning with management expectations given margin pressures. Margin expansion in Q1 FY25 was strong (19.4%), driven by cost efficiencies and rationalization, but may moderate going forward. Capacity exp

DOMS IndustriesQ1 FY25Household Products

DOMS Industries Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹2,098P/E: 58.1Market Cap: ₹12.6K CrSector: Household Products

Management growth scorecard

Revenue

Category 2

Margin

Category 4

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

The company targets about 20% core business revenue growth in FY25, with additional growth from inorganic acquisitions (e.g., Uniclan).
Office supplies like pens have a growing production capacity, with pen manufacturing capacity recently expanded to 3 million pens/day and plans to increase pencil capacity by about 2.5 million/day soon.
The new pen production unit (1 million pens/day capacity) started operations towards end of June 2024 and utilization will steadily increase.
The diaper business (Uniclan acquisition) is expanding capacity from 400 million to 650 million pieces/year, expected to contribute to growth.
The company focuses primarily on the domestic market for expansion; international sales are currently stable but expected to improve with increased manufacturing capacity.
New product launches (e.g., SKIDO brand, new SKUs in pens) and capacity additions are expected to drive volume and sales growth organically.
Overall, management is optimistic to achieve close to 20-25% top-line growth.

Margin guidance

Category 4

DOMS targets a revenue growth of around 20% in FY25 for its core business, with additional growth expected from inorganic acquisitions like Uniclan.
EBITDA margins are expected to normalize to about 17% for the full year, considering increased raw material costs, integration of Uniclan (which has a lower margin), and ESOP expenses.
PAT was projected around INR 210 crores by an analyst, aligning with management expectations given margin pressures.
Margin expansion in Q1 FY25 was strong (19.4%), driven by cost efficiencies and rationalization, but may moderate going forward.
Capacity expansions, especially in pens & pencils, and new product launches are expected to drive organic growth.
Uniclan acquisition and expansion in baby care segment represents a positive opportunity to broaden future growth avenues.
DOMS aims to sustain growth momentum via innovation, distribution strength, and selective inorganic expansion in complementary categories.

See what DOMS Industries management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

DOMS Industries is currently infusing approximately INR 29 crores as primary infusion in Uniclan as part of their acquisition, with the balance being secondary purchase from existing promoters (Page 12).
This primary infusion will support Uniclan's capital requirements for mid-term, including capital expenses for expanding diaper manufacturing capacity and starting the wet wipe segment (Page 12).
The current net debt level of Uniclan is about INR 38 crores. Post-capital infusion, some of the infusion will be used for capex and working capital (Page 12).
The company did not mention any specific plans for fresh fundraising through debt or equity beyond this acquisition infusion.
DOMS plans organic capacity expansions funded primarily through internal accruals—INR 35 crores spent on capex in Q1 FY25 for pen capacity and ongoing projects (Page 3).
No explicit mention of additional equity or debt fundraising in near future beyond these planned investments was stated.

Order book

The transcript from the document "1284580.pdf" does not provide specific information regarding the current or expected order book or pending orders for DOMS Industries Limited. The discussion mainly focuses on: - Capacity expansions in pens and pencils manufacturing. - Launching of new SKUs, especially in the pen segment. - Expansion into new product categories like diapers (Uniclan acquisition), toys, and possibly other children's products. - Continued focus on the INR 5 price point in pens with new variants in INR 5 and INR 10 segments. - Positive momentum in sales and growth guidance centered around 20% top-line growth, excluding inorganic additions. - No explicit details on the order book size or pending orders were mentioned in the provided transcript. If more precise details on orderbook are required, it might be necessary to review other sections of company communications or quarterly reports.

See what DOMS Industries management said on order book — free account, 30 seconds.

Capex plans

Yes

DOMS is expanding manufacturing capacities, including a new 44-acre land parcel under construction since Q1 2024 for core stationery products.
Recently commercialized an additional pen manufacturing capacity of 1 million pens per day, increasing total capacity to 3 million pens/day soon.
Plans to add pencil manufacturing capacity by end of FY25 or early FY26, increasing from 5.7 million to about 8-8.5 million pieces per day.
Acquisition of Uniclan (diaper business) includes a capital infusion of approx. INR 29 crores planned for capacity expansion (adding a third diaper manufacturing line with 250 million pieces/year capacity) and wet wipes segment.
Future inorganic expansions in unrelated categories (e.g., toys, baby care) are planned; core stationery capacity growth will continue organically.
Capital expenditure in Q1 FY25 was around INR 35 crores, mainly on plant machinery, equipment, and construction related to pens and 44-acre land parcel.

Track DOMS Industries — get its next earnings analysis in your feed

How does DOMS Industries rank vs peers in Household Products?

Pro feature

ThisDOMS Industries

Rev 2Mar 4

See where DOMS Industries sits in Household ProductsSee which companies these are, and every other name in the sector.Open rankings

How does DOMS Industries rank in Household Products?

Compare DOMS Industries against every Household Products company (Q1 FY25) on revenue, margins and earnings-call signals.

View Household Products leaderboard →

What DOMS Industries's management said in earlier quarters

Others in Household Products this season

Flair Writing (Q3 FY25)
. Key concall takeaways from Flair Writing's Q3 FY25 earnings call — and how it ranks against sector peers.
Navneet Educat. (Q1 FY27)
45-50 crore additional in Q2 vs Q1). Key concall takeaways from Navneet Educat.'s Q1 FY27 earnings call — and how it ranks against sector peers.
Flair Writing (Q1 FY27)
Q1 FY27 Capex: INR 43.42 crores total . Key concall takeaways from Flair Writing's Q1 FY27 earnings call — and how it ranks against sector peers.
Eveready Inds. (Q1 FY27)
Alkaline battery segment growing at ~20% CAGR, driving overall battery market growth. Key concall takeaways from Eveready Inds.'s Q1 FY27 earnings call — and…

Compare:vs Jyothy Labs Ltd vs Navneet Educat.vs Flair Writing

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →